Signe Risbøl Vils

6PUBLICATIONS
11CO-AUTHORS
HaematologyInnate immunityPredictive and prognostic markersRespiratory diseasesRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2023
Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome.

Signe Risbøl Vils, Anne Troldborg, Anne-Mette Hvas

|Nov 29, 2022
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders.

Christian Ammitzbøll, Marianne Kragh Thomsen, Jakob Bøgh Andersen

|Mar 02, 2022
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.

Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels

|Sep 03, 2021
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.

Lars Erik Bartels, Christian Ammitzbøll, Jakob Bøgh Andersen

|Jul 17, 2021
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Christian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen

|May 31, 2021
Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid Arthritis.

Christian Ammitzbøll, Jakob Bøgh Andersen, Signe Risbøl Vils

Pageof 1

Frequent Collaborators

4 joint publications

Christian Ammitzbøll

4 joint publications

Christian Erikstrup

4 joint publications

Anne Troldborg

3 joint publications

Lars Erik Bartels